Profit taking weighs down Marinus Pharmaceuticals

Investors locked in profits on Marinus Pharmaceuticals Inc. (Nasdaq: MRNS). Shares of the biopharmaceutical dropped $1.44 to close at $7.89.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.